Cite

HARVARD Citation

    Hosono, A. et al. (n.d.). 1151PPhase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors. Annals of oncology. p. . [Online]. 
  
Back to record